• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达福氏志贺菌2a菌体抗原的aroD缺失减毒大肠杆菌K12-福氏志贺菌杂交疫苗的基因型和表型特征

Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen.

作者信息

Newland J W, Hale T L, Formal S B

机构信息

Department of Enteric Infections, Walter Reed Army Institute of Research, Washington, DC 20307.

出版信息

Vaccine. 1992;10(11):766-76. doi: 10.1016/0264-410x(92)90512-i.

DOI:10.1016/0264-410x(92)90512-i
PMID:1441732
Abstract

The construction and characterization of EcSf2a-2, an aroD-deleted Escherichia coli-Shigella hybrid vaccine carrying chromosomal and plasmid genes from Shigella flexneri and expressing S. flexneri 2a somatic antigen in association with E. coli K12 core are described. Expression of hybrid lipopolysaccharide and deletion of aroD resulted in the attenuation of phenotypic characteristics associated with pathogenicity. The addition of an aroD deletion results in a requirement for an aromatic precursor of para-aminobenzoic acid (PABA), an essential bacterial metabolite not present in mammalian tissues. The biosynthesis of hybrid somatic antigen prevents expression of a Sereny-positive reaction by invasive bacteria capable of expressing a plaque-positive phenotype. A functional kcpA gene is required for expression of the plaque-positive phenotype. The presence of an aroD deletion does not interfere with expression of an invasive phenotype; however, in bacteria containing a functional kcpA gene, replication and spread by invading bacteria are limited, preventing development of the plaque-positive phenotype.

摘要

描述了EcSf2a-2的构建和特性,EcSf2a-2是一种缺失aroD的大肠杆菌-志贺氏菌杂交疫苗,携带来自福氏志贺氏菌的染色体和质粒基因,并与大肠杆菌K12核心结合表达福氏志贺氏菌2a菌体抗原。杂合脂多糖的表达和aroD的缺失导致与致病性相关的表型特征减弱。aroD缺失的加入导致对哺乳动物组织中不存在的必需细菌代谢物对氨基苯甲酸(PABA)的芳香前体的需求。杂合菌体抗原的生物合成可防止能够表达噬菌斑阳性表型的侵袭性细菌产生Sereny阳性反应。功能性kcpA基因是噬菌斑阳性表型表达所必需的。aroD缺失的存在并不干扰侵袭性表型的表达;然而,在含有功能性kcpA基因的细菌中,侵袭性细菌的复制和传播受到限制,从而阻止了噬菌斑阳性表型的发展。

相似文献

1
Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen.表达福氏志贺菌2a菌体抗原的aroD缺失减毒大肠杆菌K12-福氏志贺菌杂交疫苗的基因型和表型特征
Vaccine. 1992;10(11):766-76. doi: 10.1016/0264-410x(92)90512-i.
2
Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.缺失virG(icsA)的大肠杆菌K12-福氏志贺氏菌杂交疫苗株的构建与鉴定
Vaccine. 1996 Aug;14(11):1053-61. doi: 10.1016/0264-410x(96)00002-3.
3
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.表达福氏志贺菌2a菌体抗原的侵袭性大肠杆菌K-12杂交候选疫苗在猴和人类中的安全性、免疫原性及有效性。
Infect Immun. 1992 Jun;60(6):2218-24. doi: 10.1128/iai.60.6.2218-2224.1992.
4
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.多价志贺氏菌-产肠毒素大肠杆菌候选疫苗株在豚鼠模型中的免疫原性
Vaccine. 2006 May 1;24(18):3727-34. doi: 10.1016/j.vaccine.2005.07.013. Epub 2005 Jul 22.
5
Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.用表达福氏志贺菌2a菌体抗原的侵袭性大肠杆菌K-12杂交菌株对猴子进行口服疫苗接种。
Infect Immun. 1984 Nov;46(2):465-9. doi: 10.1128/iai.46.2.465-469.1984.
6
AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.aroD基因缺失使福氏志贺菌2457T菌株减毒,并使其成为一种对猴子安全有效的口服疫苗。
Vaccine. 1993;11(8):830-6. doi: 10.1016/0264-410x(93)90358-5.
7
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.表达定居因子抗原I和产肠毒素大肠杆菌突变不耐热肠毒素的减毒福氏志贺菌2a疫苗株CVD 1204
Infect Immun. 2000 Sep;68(9):4884-92. doi: 10.1128/IAI.68.9.4884-4892.2000.
8
Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.T32-ISTRATI福氏志贺菌2a疫苗株的毒力表型及遗传特征
Vaccine. 1991 May;9(5):358-63. doi: 10.1016/0264-410x(91)90064-d.
9
Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.减毒的缺失aroA和缺失virG的福氏志贺菌2a菌株CVD 1203(一种口服活疫苗原型)的构建与特性分析
Infect Immun. 1994 Nov;62(11):5168-72. doi: 10.1128/iai.62.11.5168-5172.1994.
10
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.表达产肠毒素大肠杆菌(ETEC)CS2和CS3菌毛的福氏志贺菌2a ΔguaBA减毒株CVD 1204作为预防志贺菌和ETEC感染的活黏膜疫苗。
Infect Immun. 2001 May;69(5):3150-8. doi: 10.1128/IAI.69.5.3150-3158.2001.

引用本文的文献

1
From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review.从志贺洁到当代志贺氏菌疫苗:历史叙事回顾
Vaccines (Basel). 2022 Apr 20;10(5):645. doi: 10.3390/vaccines10050645.
2
Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.体内感染后黏膜相关恒定T细胞的激活和积累取决于微生物核黄素合成和共刺激信号。
Mucosal Immunol. 2017 Jan;10(1):58-68. doi: 10.1038/mi.2016.39. Epub 2016 May 4.
3
Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.
志贺氏菌抗原特异性 B 记忆细胞与野生型福氏志贺菌 2a 攻击的受试者疾病严重程度降低有关。
Clin Immunol. 2013 Jul;148(1):35-43. doi: 10.1016/j.clim.2013.03.009. Epub 2013 Mar 26.
4
Bacterial conjugation in the cytoplasm of mouse cells.小鼠细胞胞质中的细菌接合作用。
Infect Immun. 2008 Nov;76(11):5110-9. doi: 10.1128/IAI.00445-08. Epub 2008 Sep 2.
5
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.志贺氏菌疫苗的临床试验:在漫长而艰难的道路上前进两步,后退一步。
Nat Rev Microbiol. 2007 Jul;5(7):540-53. doi: 10.1038/nrmicro1662.
6
Complete DNA sequence and analysis of the large virulence plasmid of Shigella flexneri.福氏志贺氏菌大毒力质粒的完整DNA序列及分析
Infect Immun. 2001 May;69(5):3271-85. doi: 10.1128/IAI.69.5.3271-3285.2001.
7
Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.霍乱毒素和不耐热肠毒素的天然及突变形式可有效增强减毒活疫苗和热灭活志贺氏菌疫苗的保护效力。
Infect Immun. 1999 Nov;67(11):5841-7. doi: 10.1128/IAI.67.11.5841-5847.1999.
8
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.用福氏志贺菌2a减毒株SC602进行志贺菌病疫苗接种。
Infect Immun. 1999 Jul;67(7):3437-43. doi: 10.1128/IAI.67.7.3437-3443.1999.
9
Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.针对1型痢疾志贺菌的减毒活疫苗候选株的构建与特性分析
Infect Immun. 1997 Jun;65(6):2112-8. doi: 10.1128/iai.65.6.2112-2118.1997.
10
Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a.用强毒福氏志贺菌2a黏膜感染BALB/c小鼠所引发的单克隆抗体的特异性
Clin Diagn Lab Immunol. 1996 Sep;3(5):584-9. doi: 10.1128/cdli.3.5.584-589.1996.